NASDAQ:SPRB

Spruce Biosciences Stock Insider Trading

etoro logo Buy SPRB
*Your capital is at risk
$49.05
-0.250 (-0.507%)
At Close: Jun 03, 2026

Spruce Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -13.99. In total, the insiders bought 133.67K and sold 32.18K SPRB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-13.99
Buy 133.67K shares
Sell 32.18K shares
63% Buy Activity
Negligible or No Correlation
Buy Signal Low Confidence
May 21, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 21, 2026
Buy
Stock Option (Right to Buy)
A-Award
Barretto-ko Percival
Director
Director 1 700
Value: $89.6K
May 21, 2026
Buy
Stock Option (Right to Buy)
A-Award
Grey Michael G
Executive Chairman
CEO / President 1 700
Value: $89.6K
May 21, 2026
Buy
Stock Option (Right to Buy)
A-Award
Simpson Camilla V
Director
Director 1 700
Value: $89.6K
May 21, 2026
Buy
Stock Option (Right to Buy)
A-Award
Spiegelman Daniel K
Director
Director 1 700
Value: $89.6K
May 21, 2026
Buy
Stock Option (Right to Buy)
A-Award
Walbert Keli
Director
Director 1 700
Value: $89.6K
Mar 09, 2026
Buy
Common Stock
J-Other
Hooks Corwin Dale
Insider
Other 0
Value: $0
Mar 09, 2026
Buy
Restricted Stock Units
A-Award
Hooks Corwin Dale
Chief Commercial Officer
Officer 11 000
Value: $683.2K
Dec 31, 2025
Buy
Common Stock
A-Award
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 690
Value: $21.2K
Dec 15, 2025
Buy
Restricted Stock Units
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 480
Value: $119.4K
Dec 15, 2025
Buy
Restricted Stock Units
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 196
Value: $96.5K
Dec 15, 2025
Sell
Common Stock
F-InKind
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 608
Value: $49.0K
Dec 15, 2025
Buy
Common Stock
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 196
Value: $96.5K
Dec 15, 2025
Buy
Restricted Stock Units
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 496
Value: $40.0K
Dec 15, 2025
Sell
Common Stock
F-InKind
Gharib Samir M.
President And CFO
CEO / President 178
Value: $14.4K
Dec 15, 2025
Buy
Common Stock
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 513
Value: $41.4K
Dec 15, 2025
Sell
Common Stock
F-InKind
Gharib Samir M.
President And CFO
CEO / President 184
Value: $14.8K
Dec 15, 2025
Buy
Common Stock
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 496
Value: $40.0K
Dec 15, 2025
Buy
Restricted Stock Units
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 513
Value: $41.4K
Dec 15, 2025
Buy
Common Stock
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 480
Value: $119.4K
Dec 15, 2025
Sell
Common Stock
F-InKind
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 752
Value: $60.7K
Dec 11, 2025
Sell
Stock Option (Right to Buy)
D-Return
Ways Douglas Kirk
Interim Chief Medical Officer
Officer 400
Value: $67.8K
Dec 11, 2025
Buy
Restricted Stock Units
A-Award
Ways Douglas Kirk
Interim Chief Medical Officer
Officer 5 000
Value: $445.0K
Dec 11, 2025
Buy
Restricted Stock Units
M-Exempt
Ways Douglas Kirk
Interim Chief Medical Officer
Officer 1 250
Value: $111.2K
Dec 11, 2025
Buy
Common Stock
M-Exempt
Ways Douglas Kirk
Interim Chief Medical Officer
Officer 1 250
Value: $111.2K
Dec 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ways Douglas Kirk
Interim Chief Medical Officer
Officer 400
Value: $41.7K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SPRUCE BIOSCIENCES, INC.
Spruce Biosciences
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adu...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE